Author of the publication

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

No persons found for author name Fabre, Myriam
add a person with the name Fabre, Myriam
 

Other publications of authors with the same name

Preclinical efficacy of endoglin-targeting antibody-drug conjugates for the treatment of Ewing sarcoma, , , , , , , , , and 16 other author(s). Clinical Cancer Research, (November 2018)OMTX705, a powerful stroma-targeting ADC to treat invasive tumors with low response to immunotherapeutic anti-PD-1 treatments, , , , , , , , , and 1 other author(s). Abstract Book of the 43rd ESMO Congress (ESMO 2018), 29, Suppl. 8, page 414. Elsevier, Oxford Univ. Press, (2018)OMTX705, a Novel FAP-Targeting ADC demonstrates Activity in Chemotherapy and PD1-Resistant Solid Tumors Models, , , , , , , , , and 7 other author(s). Clinical Cancer Research, (March 2020)Preclinical efficacy of endoglin-targeting antibody-drug conjugates for the treatment of Ewing sarcoma, , , , , , , , , and 16 other author(s). Clinical Cancer Research, 25 (7): 2228-2240 (2019)OMTX705, a Novel FAP-Targeting ADC Demonstrates Activity in Chemotherapy and Pembrolizumab-Resistant Solid Tumor Models, , , , , , , , , and 7 other author(s). Clinical Cancer Research, 26 (13): 3420-3430 (2020)